In nonhospitalized, unvaccinated adults with COVID-19, molnupiravir reduced hospitalization or death at 29 d. Sacks HS. Ann Intern Med 2022 Apr 5. doi: 10.7326/J22-0017.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sacks HS. In nonhospitalized, unvaccinated adults with COVID-19, molnupiravir reduced hospitalization or death at 29 d. Ann Intern Med 2022 Apr 5. doi: 10.7326/J22-0017.
PMID: 35377719